ARCBEST CORPORATION (ARCB): what the price requires

At today's price, ARCBEST CORPORATION (ARCB) is priced for today's economics sustained for ~12.8 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/ARCB

Headline

FieldValue
TickerARCB
CompanyARCBEST CORPORATION
Current price$150.95/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed5.3%
Operating margin today2.5%
Margin expansion implied+2.8pp
Must persist for12.8y
Multiple paid37x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 11.9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.2 years.

Reconcile: at the x-ray's 9.3% required return this reads ~7.5 years; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history+0.24σ
sustained it ~10 years at this level14%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple; asset-based/earnings-power/growth-DCF land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset7.05x4expensive
Earnings2.89x4expensive
Relative1.12x3expensive
Growth1.72x3expensive

Families that justify the price: Relative Families that call it expensive: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.6%); the inversion above states its own rate.

Per-Model Detail (n=14)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$57.092.64xyesFCF base $0.1B, growth -2% (input: historical growth), terminal g 0.5%, WACC 8.6%, 5yr projection
DCF Exit MultipleGrowth$124.431.21xyesExit EV/EBITDA: 12.4x / 14.4x / 16.4x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$106.461.42xyesP/E 32.09x (blended: static sector reference 20x + trailing (TTM) 60x), scenarios: 27.1x / 32.1x / 37.1x (bear / base = reference held flat / bull), EV/EBITDA 13x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$27.075.58xyesBV/sh $57.59, ROE (TTM) 4.3%, ke 9.3%
Two-Stage Excess ReturnAsset$17.698.53xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$87.781.72xyesRev $4.0B, growth -2% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.8x / 1.0x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$76.571.97xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.24B × (1−21%) / WACC 8.6% → EPV (no growth)
Residual IncomeAsset$15.219.92xyesBV $57.59 + 5yr PV of (ROE (TTM) 4.3% − Kₑ 9.3%) × BV; BV grows 2.8%/yr
Graham NumberAsset$56.232.68xyes√(22.5 × EPS $2.44 × BVPS $57.59) — Graham's conservative floor
EV/EBITDA RelativeRelative$134.621.12xyesEBITDA $0.26B × sector EV/EBITDA 13.0x
FCF YieldEarnings$54.772.76xyesFCF $149.8M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$49.783.03xyesSBC-adj FCF $0.14B (FCF $0.15B − SBC $0.01B) capitalized at Kₑ
Ben Graham FormulaEarnings$2.0474.00xyesEPS $2.44 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$1.08139.77xyesBV $57.59 × (ROIC 0.2% / WACC 8.6%) (excluded from median)
P/Sales SectorRelative$361.880.42xyesRevenue $4.04B × sector P/S 2.0x
PEG Fair ValueRelativeno
Earnings YieldEarnings$26.385.72xyesEPS $2.44 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$137.2m
Net debt / NOPAT (after-tax)1.70x
Net debt / operating income (pre-tax)1.35x
Share count CAGR (buyback)-3.6%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

The capital allocation tells you what management thinks of its own stock at the bottom of a cycle: it keeps buying. ArcBest has reduced its share count by about 3.6% a year, repurchasing shares through a freight recession that has compressed margins across the industry, and it does so from a position of balance-sheet strength, with net debt of only about $137 million against trailing operating income near $87 million. Buying back stock when earnings are depressed is the disciplined move, because it retires the most shares per dollar precisely when the price reflects trough conditions. The flat-to-falling share count is the clearest evidence management believes the current margin is a cyclical low, not a new normal.

The LTL network is the durable asset, and the recent quarter showed it taking share even in a weak market. Asset-based revenue grew despite the downturn, and tonnage per day rose 6.5% year over year on a 2% increase in shipments and 5% heavier weight per shipment. The 10-K explains the demand driver plainly: tonnage is "directly affected by industrial production and manufacturing; distribution; residential and commercial construction; consumer spending, primarily in the North American economy." That ties ArcBest to the industrial cycle, and the cycle has been soft, yet the company grew volume by onboarding new core LTL customers. Winning volume in a down market is the sign of a network gaining density, which is the source of LTL profitability.

The pricing and the turn are where the bull case gets concrete. Contract renewals and deferred pricing agreements averaged a 6.3% increase in the first quarter, and management described LTL industry pricing as rational. ArcBest guided second-quarter asset-based operating ratio to improve 400 to 500 basis points sequentially, ahead of its 10-year historical average seasonal improvement of 350 basis points. The asset-light segment also returned to a small operating profit from a loss. Against a trucking cohort that includes Old Dominion's peers J.B. Hunt, Knight-Swift, and Saia's competitors, the bull case is that ArcBest is gaining LTL density, holding price, and positioned for operating leverage when freight demand recovers, all while shrinking the share count at trough prices.

Bear Case

The bear case is moat-erosion under cyclical stress, and the operating ratio is where it shows. Asset-based operating ratio climbed to 97.3% in the first quarter, meaning the segment spent 97.3 cents to earn a dollar of revenue, and operating income fell to $17.5 million as higher contractual wages, benefits, and depreciation outran the revenue line. An LTL carrier's whole value is its ability to run a low operating ratio through density and pricing; when costs rise faster than revenue even as tonnage grows, the network is not converting volume to profit. The 10-K flags the structural pressure directly, citing "ongoing weakness in the manufacturing sector and evolving freight dynamics, including the shift of some heavier LTL shipments" away from its mix. That shift is exactly the kind of erosion the bull case has to overcome.

The valuation is the harder problem because the price assumes a recovery the cycle has not delivered. At about 35 times operating income, the market is paying for growth held at the self-funding ceiling for roughly 13 years, a duration only about 14% of comparable fast-growers have ever sustained. The current operating margin is a thin 2.2%, cyclically depressed, so the multiple is enormous against trailing earnings. The price is, in effect, capitalizing a normalized margin that has not yet returned, and the static methods agree it is stretched: the asset-value, earnings-power, and even forward-growth lenses all flag the price as expensive, with only the relative-multiple lens reaching it. There is no conservative method defending the level.

The dependency, then, is entirely on the freight cycle turning and the operating ratio falling back toward better levels. ArcBest guided to a sequential margin improvement, but freight cycles are notoriously hard to time, and a prolonged industrial slowdown keeps the operating ratio elevated regardless of how well the company executes. The balance sheet is sound, so this is not a solvency bear; it is a multiple bear. A trucking company earning a 2.2% margin and priced at 35 times operating income has priced in the recovery, and if the recovery is slower or shallower than the guidance implies, the multiple compresses toward what the depressed earnings actually support. The bear does not need ArcBest to be poorly run; it needs the freight cycle to disappoint the recovery the price has already booked.

Valuation

The price is a bet on normalization, and the numbers make that explicit. At about 35 times operating income against a thin 2.2% trailing margin, the price is not valuing what ArcBest earns now; it is valuing what it earns when the freight cycle recovers and the operating ratio falls. Inverted, the price embeds growth held at the self-funding ceiling for roughly 13 years, which is the framework's way of saying the multiple assumes a long, sustained run of the better margins that the cycle has not yet provided. The trailing earnings are cyclically depressed, so the headline multiple overstates the demand on the business, but the direction is clear: this is a recovery valuation, not a current-earnings valuation.

The methods split the way they do for a cyclical priced for the upturn. The asset-value, earnings-power, and forward-growth lenses all flag the price as expensive, sitting well above where they land, because they read the trough earnings. Only the relative-multiple lens reaches the price, which makes sense if peers are similarly priced for a freight recovery. When the static methods say expensive and only the peer lens agrees with the price, the price is leaning on the assumption that the whole group re-rates as the cycle turns. That is a defensible bet if the recovery comes, but it is a bet on the cycle, and the valuation has little support beneath it if the recovery stalls.

Solvency is the reassuring part and keeps this a multiple story rather than a survival one. Net debt of about $137 million is a modest 1.6 times trailing operating income, the company is not burning cash, and it has continued to buy back stock, shrinking the share count about 3.6% a year. A strong balance sheet through a downturn is exactly what lets a cyclical wait for the recovery and repurchase shares at trough prices. Against the trucking cohort, ArcBest is gaining LTL volume and holding pricing, but the price has already credited the margin recovery, so the question for the buyer is whether the freight cycle delivers the operating-ratio improvement the guidance points to and the multiple requires.

Catalysts

The first-quarter 2026 results were mixed but pointed to a turn. Revenue rose 3.3% to $998.8 million, and while the company posted a small net loss of $(0.05) per share, adjusted EPS of $0.32 beat consensus by three cents. The asset-based LTL segment grew revenue 1.3% to $655.0 million on tonnage up 6.5%, but operating income fell to $17.5 million as the operating ratio rose to 97.3% on higher wages and depreciation. The asset-light segment improved from a loss to a small operating profit.

The forward signals were the more important part of the print. Contract renewals and deferred pricing averaged a 6.3% increase, management called LTL pricing rational, and it guided second-quarter asset-based operating ratio to improve 400 to 500 basis points sequentially, ahead of the 10-year average seasonal gain of 350 basis points. A larger-than-seasonal margin improvement is the catalyst the bull case is built on, and management cited strong April momentum heading into the quarter.

The forward watch items are the operating ratio and the freight cycle. Whether the guided 400-to-500-basis-point sequential improvement materializes, and whether contract pricing holds at mid-single digits, are the swing factors for the margin recovery the price assumes. Because tonnage tracks industrial production and manufacturing, the broader freight and manufacturing data are the external variables with the most leverage on results, and a sustained turn there is what would validate the recovery valuation, while continued manufacturing weakness is the scenario the elevated multiple is most exposed to.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

ArcBest Q1 2026 results, 2026 · ArcBest FY2025 10-K

View the full interactive ARCB report on boothcheck